Without a rigorous discussion of the pros and cons of QbD, its tremendous benefits will be lost.
The development of a skilled labor force is essential for an expanding biopharmaceutical industry.
How to successfully balance patient safety with supply-chain management
Avoid manufacturing failures by effective viral inactivation.
Can increase in ionic strength result in higher viscosity?
Manufacturing challenges surround the use of IgM monoclonal antibodies, but these can be overcome with current technology.
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Quality by Design and Design Space can be used by companies to enhance process understanding, improve scientific rigor, and enhanced qualitative and quantative performance, as well as cost savings.
New techniques can overcome bottlenecks in existing facilities.
Communication between contract analytical laboratory and client is extremley important when out-of-specification (OOS) results arise.
Productivities similar to those achieved with stirred tanks can be achieved with disposable bioreactors.
The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.
Can increase in ionic strength result in higher viscosity?
There are several steps that you can take to ensure that you get the greatest benefit from consultants.
Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.
BioPharm talks with Tarja Mottram, CEO of Action for Results, on design-for-value concepts, management, and cross-functionality.
The authors investigate the sufficiency of high-temperature short-time treatment in inactivate mouse minute virus contamination.
"A systematic approach taken by a company involved making an assessment of internal capabilities, strengths, and needs before the selection process."
New technologies and adaptations of existing technologies can improve platform processes.
It is essential to build and maintain a good working relationship between the client and contract research organization.
A top-10 list of critical legal issues that biotech start-ups should make an effort to address, even when the capital squeeze is intense.
The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.
Data on the performance and variability of different formats.
Gene fusion tags can improve the yield and solubility of many recombinant proteins. This article discusses the most popular fusion tags and the proteases used to remove them, with special reference to recently introduced technologies.
The authors present scale-up from a 5-L fermentor to a 50-L pilot-scale using the criterion of constant power consumption per unit liquid volume.